Cogent Biosciences (COGT) Interest Coverage Ratio (2025 - 2026)

Cogent Biosciences (COGT) recorded quarterly Interest Coverage Ratio of 85.41 in Q1 2026, down 10.66% quarter-over-quarter from 77.19 in Q4 2025.

Cogent Biosciences (COGT) Interest Coverage Ratio (2025 - 2026) Analysis & Trends

Cogent Biosciences' Interest Coverage Ratio history runs 2 years deep, the most recent figure standing at 85.41 for Q1 2026.

In Q1 2026, Interest Coverage Ratio changed N/A year-over-year to 85.41; the TTM figure through Mar 2026 stood at 84.69 (changed N/A YoY), while the FY2025 annual figure was 108.87, changed N/A from the prior year.
Interest Coverage Ratio was 85.41 for Q1 2026 at Cogent Biosciences, down from 77.19 in the prior quarter.
In the past five years, Interest Coverage Ratio ranged from a high of 57.13 in Q3 2025 to a low of 240.71 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	3.58
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-258.33
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	11.50
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	547.67
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	-
9	Abivax	91.71 Bn	91.71 Bn	-	11.79
10	Cogent Biosciences	5.09 Bn	4.22 Bn	-	-85.41

Download Data